Cephalon has been conducting traditional pre-launch activities for Treanda, the first new therapy approved for the treatment of chronic lymphocytic leukemia (CLL) since 2001.
SIGN IN WITH ONE OF YOUR SOCIAL ACCOUNTS
Sign in with your MMM account
Keep me signed in Forgot your password?
REGISTER FOR FREE WITH ONE OF YOUR SOCIAL ACCOUNTS
REGISTER FOR FREE WITH A MMM ACCOUNT
Enter your MMM registration email address to receive a new password.